Literature DB >> 7547221

Trends of skin cancer in the Canton of Vaud, 1976-92.

F Levi1, S Franceschi, V C Te, L Randimbison, C La Vecchia.   

Abstract

Trends in incidence and mortality for basal cell carcinomas (BCC), squamous cell carcinomas (SCC) and cutaneous malignant melanoma (CMM) for the period 1976-92 were analysed using data from the Cancer Registry of the Swiss Canton of Vaud. Among the 12,473 cases registered, 63% were basal cell carcinomas, 25% squamous cell cancers, 9% cutaneous malignant melanomas and 3% other miscellaneous histological types. Age-standardised incidence rates increased substantially for all histological types considered, from 44% increase for BCC in males to a more than 3-fold increase for SCC in females, with only signs of a levelling off in 1991-92, following a peak of incidence rates in 1986-90. From 1976-80 to 1991-92 CMM incidence increased by approximately 80% in both sexes. In 1991-92, age-standardised (world) incidence rates per 100,000 were 69.3 for basal cell, 29.1 for squamous cell cancers and 11.5 for melanomas in males, and, respectively, 62.2, 18.0 and 12.3 in females. With respect to mortality, in males rates increased for both non-melanocytic cancer (> 40%) and CMM (> 53%) whereas in females CMM, BCC and SCC rates remained approximately stable over the calendar periods examined. In 1991-92, age-standardised mortality rates per 100,000 were 2.6 for melanoma and 0.7 for other skin cancers in males, and, respectively, 1.6 and 0.2 in females. Upward trends in incidence were also present, and relatively homogeneous across, various age groups examined. However, SCC and CMM levelled off over the last period, and some decline was apparent in males below age 45. Separate analysis by anatomical site showed substantial increases in the head and neck for SCC and BCC, and in the trunk for CMM. In 1991-92, middle-aged women had almost equalled male incidence rates of BCC and SCC. A female excess of CMM incidence seemed to have disappeared since 1981-86. The increase in skin cancer incidence thus continued in this population up to the late 1980s, with a plateau only after 1990.

Entities:  

Mesh:

Year:  1995        PMID: 7547221      PMCID: PMC2034057          DOI: 10.1038/bjc.1995.460

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  30 in total

1.  Increases in mortality from cutaneous melanoma in southern Europe.

Authors:  S Franceschi; C La Vecchia; E Negri; F Levi
Journal:  Int J Cancer       Date:  1992-04-22       Impact factor: 7.396

Review 2.  The epidemiology of cutaneous malignant melanoma: aetiology and European data.

Authors:  S Franceschi; C La Vecchia; F Lucchini; M Cristofolini
Journal:  Eur J Cancer Prev       Date:  1991-10       Impact factor: 2.497

Review 3.  Early detection of melanoma: an ounce of prevention may be a ton of work.

Authors:  H K Koh; A C Geller; D R Miller; R A Lew
Journal:  J Am Acad Dermatol       Date:  1993-04       Impact factor: 11.527

4.  Prevention of cutaneous melanoma: an epidemiological evaluation of the Swiss campaign.

Authors:  J L Bulliard; L Raymond; F Levi; G Schuler; F Enderlin; S Pellaux; J Torhorst
Journal:  Rev Epidemiol Sante Publique       Date:  1992       Impact factor: 1.019

5.  Trends in non-melanocytic skin cancer treated in Australia: the second national survey.

Authors:  R Marks; M Staples; G G Giles
Journal:  Int J Cancer       Date:  1993-02-20       Impact factor: 7.396

6.  Non-melanoma skin cancer: ten years of cancer-registry-based surveillance.

Authors:  J Kaldor; D Shugg; B Young; T Dwyer; Y G Wang
Journal:  Int J Cancer       Date:  1993-04-01       Impact factor: 7.396

7.  Cutaneous malignant melanoma, Scotland, 1979-89. The Scottish Melanoma Group.

Authors:  R MacKie; J A Hunter; T C Aitchison; D Hole; K Mclaren; R Rankin; K Blessing; A T Evans; A W Hutcheon; D H Jones
Journal:  Lancet       Date:  1992-04-18       Impact factor: 79.321

8.  Increasing incidence of cutaneous melanoma in Queensland, Australia.

Authors:  R MacLennan; A C Green; G R McLeod; N G Martin
Journal:  J Natl Cancer Inst       Date:  1992-09-16       Impact factor: 13.506

9.  Primary malignant melanoma of skin in four regions of New Zealand.

Authors:  K Cooke; B McNoe; M Hursthouse; R Taylor
Journal:  N Z Med J       Date:  1992-08-12

10.  Interstate differences in incidence and mortality from melanoma. A re-examination of the latitudinal gradient.

Authors:  M E Jones; D Shugg; T Dwyer; B Young; A Bonett
Journal:  Med J Aust       Date:  1992-09-21       Impact factor: 7.738

View more
  8 in total

1.  A gene for an autosomal dominant scleroatrophic syndrome predisposing to skin cancer (Huriez syndrome) maps to chromosome 4q23.

Authors:  Y A Lee; H P Stevens; E Delaporte; U Wahn; A Reis
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

2.  A Rare Syndrome Resembling Scleroderma: Huriez Syndrome.

Authors:  Nil Su Çelik; Şirin Yaşar; Sema Aytekin; Pembegül Güneş
Journal:  Skin Appendage Disord       Date:  2017-08-12

3.  Skin Cancer Development in Solid Organ Transplant Recipients in Switzerland (Swiss Transplant Cohort Study).

Authors:  Nadja Angela Stenz; Susanne Stampf; Andreas W Arnold; Antonio Cozzio; Michael Dickenmann; Olivier Gaide; Mirjam Harms; Robert E Hunger; Emmanuel Laffitte; Michael Mühlstädt; Mirjam Nägeli; Günther F L Hofbauer
Journal:  Dermatology       Date:  2020-11-23       Impact factor: 5.366

4.  Breslow thickness in the Netherlands: a population-based study of 40 880 patients comparing young and elderly patients.

Authors:  S Kruijff; E Bastiaannet; A B Francken; M Schaapveld; M van der Aa; H J Hoekstra
Journal:  Br J Cancer       Date:  2012-06-19       Impact factor: 7.640

5.  Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers.

Authors:  F Levi; L Randimbison; V C Te; C La Vecchia
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

6.  Non-melanoma skin cancers and glucocorticoid therapy.

Authors:  M R Karagas; G L Cushing; E R Greenberg; L A Mott; S K Spencer; D W Nierenberg
Journal:  Br J Cancer       Date:  2001-09-01       Impact factor: 7.640

7.  Poikiloderma a varied presentation - Huriez syndrome.

Authors:  Priyadarshini Kharge; Carol Fernendes; Vijayeeta Jairath; Madan Mohan; Suresh Chandra
Journal:  Indian Dermatol Online J       Date:  2015 Jan-Feb

8.  Risk of cancer in persons with AIDS in Italy, 1985-1998.

Authors:  L Dal Maso; S Franceschi; J Polesel; C Braga; P Piselli; E Crocetti; F Falcini; S Guzzinati; R Zanetti; M Vercelli; G Rezza
Journal:  Br J Cancer       Date:  2003-07-07       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.